Advertisement

Topics

Drug pricing to remain a challenge for the industry

18:25 EDT 4 May 2017 | Generics and Biosimilars Initiative

Pricing is the foremost issue facing the pharmaceutical industry, and is especially prominent in the US. Pharmaceutical companies are renowned for charging more for their drugs in the US than in other Western nations, sometimes by up to five times. 

Original Article: Drug pricing to remain a challenge for the industry

NEXT ARTICLE

More From BioPortfolio on "Drug pricing to remain a challenge for the industry"

Quick Search
Advertisement